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Sequencing of the blaKPC-positive strain Proteus mirabilis AOUC-001 was performed using both the MiSeq and PacBio RS II
platforms and yielded a single molecule of 4,272,433 bp, representing the complete chromosome. Genome analysis showed the
presence of several acquired resistance determinants, including two copies of blaKPC-2 carried on a fragment of a KPC-producing
plasmid previously described in Klebsiella pneumoniae.
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Proteus mirabilis is one of the leading agents of urinary tractinfections and can cause a number of different health care-
associated infections, including mainly respiratory tract and skin
infections, but also bacteremia (1). Due to a decreased suscepti-
bility to imipenem and an intrinsic resistance to polymyxins and
tetracyclines (including tigecycline), the acquisition of -lactam
resistance traits by P. mirabilis might seriously limit treatment
options. KPC-type carbapenemases have become the most preva-
lent acquired carbapenemases in Klebsiella pneumoniae in several
areas worldwide (2) and have been sporadically detected also in
other Enterobacteriaceae and in Gram-negative nonfermenters
(3–6). The acquisition of blaKPC by P. mirabilis represents a rare
event, and only a few descriptions have been reported to date
(7–9). In this report, we announce the first complete genome se-
quence of a P. mirabilis strain carrying the blaKPC-2 gene.
P. mirabilis AOUC-001 was isolated in 2013 from the blood
culture from an inpatient admitted to the Santa Maria Annunziata
Hospital (Florence, Italy). A molecular test performed directly on
positive blood culture, using the FilmArray platform (Biofire Di-
agnostics, UT), detected the presence of the blaKPC gene.
Bacterial DNA was subjected to whole-genome sequencing us-
ing the MiSeq (Illumina, Inc., CA) and the PacBio RS II (Pacific
Biosciences, CA, USA) platforms, which generated 4,643,660 and
1,841,288 reads, respectively. Short and long raw reads were pro-
cessed with the PBcR hybrid assembly pipeline (10), producing 8
scaffolds (largest scaffold, 1.96 Mb; N50, 1.52 Mb; L50, 2; average
GC content, 39.42%). Genome finishing was achieved by man-
ual inspection of the draft assembly, exploiting PacBio long reads
for resolution of large repeats, and using short reads to close small
gaps (11). The final de novo assembly generated a single molecule
of 4,272,433 bp, with a raw coverage of 260, representing the
complete chromosome of AOUC-001.
A total of 3,853 coding sequences, 83 tRNAs, 22 rRNAs, and 1
type-IE clustered regularly interspaced short palindromic repeat
(CRISPR)-associated (Cas) system were identified by the NCBI
Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm
.nih.gov/genome/annotation_prok).
Screening for known virulence determinants (12) revealed the
presence of genes associated with adhesion (mannose-resistant/
Proteus-like fimbria [MR/P], P. mirabilis fimbria [PMF], and
ambient-temperature fimbria [ATF] operons), motility (flgE,
fliFL, cheW, and flaD), iron chelation (hmurR2, znuC, and nrp
operon), and production of toxic compounds (pta, hpmA, and
zapA).
The antimicrobial resistome of AOUC-001, investigated
using ResFinder (13), included acquired determinants confer-
ring resistance to aminoglycosides (aadA1, aacA4, armA,
and aph(3=)-Ic), chloramphenicol (cat and catA1), trim-
ethoprim (dfrA1), and sulfonamides (sul1). Additionally, four
different -lactamase genes (blaCMY-16, blaTEM-1, blaOXA-9, and
blaKPC-2) were detected. Interestingly, the blaKPC-2 gene was
present in two copies.
Further analysis revealed that the two blaKPC-2 copies were em-
bedded in two distinct Tn4401a transposons (14), arranged in a
tail-to-tail configuration within the chromosome of AOUC-001.
The flanking sequences of these transposons resembled the overall
architecture of pKPN101-IT (accession no. JX283456), a KPC-
encoding plasmid taken from a K. pneumoniae clinical isolate de-
scribed in Italy in 2012 (15). Overall, this arrangement suggested a
possible integration of a pKPN101-IT-like plasmid within the
chromosome of AOUC-001, an event that might have been fa-
vored by the endemic presence of KPC-producing K. pneumoniae
strains sharing the same setting (16).
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Nucleotide sequence accession number. The complete ge-
nome of P. mirabilis AOUC-001 has been deposited at NCBI un-
der the GenBank accession no. CP015347.
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